For the first-time, researchers at IMBA- Institute of Molecular Biotechnology of the Austrian Academy of Sciences – develop organoids, that mimic the onset of brain cancer. This method not only sheds light on the complex ...
Jul 27, 2018
1
84
Scientists from Queen Mary University of London, funded by the charity Brain Tumor Research, have found a new way to starve cancerous brain tumor cells of energy in order to prevent further growth.
Apr 12, 2021
2
186
In a new study, scientists have uncovered the mechanics of the blood-tumor barrier, one of the most significant obstacles to improving treatment efficacy and preventing the return of cancerous cells. The research team, led ...
Nov 1, 2022
0
603
Immunotherapy has proved effective in treating a number of cancers, but brain tumors have remained stubbornly resistant. Now, a new study suggests that a slow-growing brain tumor arising in patients affected by neurofibromatosis ...
Dec 10, 2018
0
66
Lung cancer spreads to the brain in about one-quarter of patients with an advanced form of the disease. To date, radiation has been the only treatment option, but it comes with toxic side effects. Researchers at Yale Cancer ...
Apr 14, 2020
0
302
In a first-in-world clinical trial, researchers at Sunnybrook Health Sciences Centre in Toronto, Canada, have demonstrated that magnetic resonance (MR)-guided focused ultrasound can be used to safely deliver antibody therapy ...
Oct 13, 2021
0
226
Researchers at UT Southwestern Medical Center have developed what they believe to be the first clinical application of a new imaging technique to diagnose brain tumors. The unique test could preclude the need for surgery ...
Jan 27, 2012
0
0
Laughter is the best medicine, except when it is actually the symptom of an illness. Medical residents at the University of Hawaiʻi (UH) helped to find relief for a man who suffered from nearly a lifelong affliction that ...
Nov 20, 2019
0
4
The difference between having a brain aneurysm treated the old way and a new way was aptly described as "the nutcracker" vs. "the TripTik" by a patient of Andrew Ringer, MD, professor of neurosurgery at the University of ...
Mar 7, 2014
0
0
An experimental drug targeting a common mutation in melanoma successfully shrank tumors that spread to the brain in nine out of 10 patients in part of an international phase I clinical trial report in the May 18 issue of ...
May 17, 2012
0
0
